Skip to content

Effect of transcutaneous auricular vagus nerve stimulation on postoperative quality of recovery in patients undergoing modified radical mastectomy for breast cancer: a randomized, double-blind, controlled trial

Effect of transcutaneous auricular vagus nerve stimulation on postoperative quality of recovery in patients undergoing modified radical mastectomy for breast cancer: a randomized, double-blind, controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123069
Enrollment
Unknown
Registered
2026-04-21
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. Age >=18 years old, <65 years old; 2. Patients undergoing unilateral modified radical mastectomy; 3. Clinical diagnosis of stage ?-II primary breast cancer; 4, ASAI, grade II

Exclusion criteria

Exclusion criteria: 1. Refuse to sign the trial consent; 2. Have neuropsychiatric diseases, and have a history of neurological or psychiatric diseases; 3. Cognitive impairment or inability to communicate; 4. Drug abusers; 5. Patients with implantable cardiac pacemaker; 6. The skin of the intended irritation site is damaged, red and swollen, and infected; 7. Previous history of breast cancer surgery;

Design outcomes

Primary

MeasureTime frame
Recovery quality;

Secondary

MeasureTime frame
Pain score;Anxiety score;Depression score;Sleep quality;Shoulder Pain and Disability Index;Postoperative adverse events;

Countries

China

Contacts

Public ContactJunli Cao

Affiliated Hospital of Xuzhou Medical University

caojl0310@aliyun.com+86 151 6216 0809

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026